Meeting Coverage:

American Academy of Ophthalmology

AAO: 2024

Intense Pulsed Light Therapy and Refractive Surgery

Show Description +

From the American Academy of Ophthalmology annual meeting, Jorge Alio Del Barrio, MD, PhD, highlights the role of intense pulsed light (IPL) technology for the treatment and prevention of ocular surface disorders after laser corneal refractive surgery. He recaps a randomized, controlled, double-masked trial demonstrating how patients who underwent IPL therapy were less likely to experience ocular surface disorders.

Posted: 10/25/2024

Up Next


Updates on a Novel Oral Therapy for DME

Joel A. Pearlman, MD, PhD

The Promise of a Wnt Agonist

Charles C. Wykoff, MD, PhD

The Risk of PVR Revealed

Mathew W. MacCumber, MD, PHD

The 2024 Charles L Schepens MD Lecture

Steve Charles, MD, FACS, FICS

Fellow-Eye Dosing of ABBV-RGX-314 Gene Therapy

Arshad M. Khanani, MD, MA, FASRS

Glaucoma Lasers: What’s New?

Sarah Van Tassel, MD

Visual Field Progression in the LiGHT Trial

Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

Intense Pulsed Light Therapy and Refractive Surgery

From the American Academy of Ophthalmology annual meeting, Jorge Alio Del Barrio, MD, PhD, highlights the role of intense pulsed light (IPL) technology for the treatment and prevention of ocular surface disorders after laser corneal refractive surgery. He recaps a randomized, controlled, double-masked trial demonstrating how patients who underwent IPL therapy were less likely to experience ocular surface disorders.

Posted: 10/25/2024


Please log in to leave a comment.

More From AAO: 2024 Coverage